Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid ...

Alcon’s session at the 2024 Veeva MedTech Summit in Amsterdam. Image Credit: Ross Law / GlobalData. Alcon decided to take a ...

Penumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...

The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.

Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191 aimed at treating advanced solid tumours.

Oak Hill Bio and Chiesi have enrolled the first European patient in a Phase IIb study for OHB-607, to prevent BPD in infants.

The community screening programme charts an effective, affordable framework for TB control in the Canadian province of ...

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of ...

Novo Nordisk has reported positive outcomes from part one of the ESSENCE trial of semaglutide 2.4 mg in treating MASH and ...